NIH Seeks Comments on Chimpanzee Research Tracking Form
Published Date: 6/23/2026
Notice
Summary
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Funding Limited to Noninvasive Chimpanzee Research
The NIH will not fund research involving chimpanzees in new or competing projects unless the proposed work meets the definition of "noninvasive research" in the Standards of Care (42 CFR part 9). Proposals that do not meet that definition will not receive NIH funding.
Mandatory Chimpanzee Form for Funding
If you propose noninvasive research involving chimpanzees and want NIH support or approval, you must complete the Chimpanzee Research Use Form. The NIH will review the form before making funding decisions or allowing the research to begin.
Estimated Time Burden for Respondents
NIH estimates no monetary costs to respondents other than time: 30 respondents will each spend about 30 minutes per response, for a total estimated annualized burden of 15 hours. OMB approval is being requested for three years and the current control expires 7/31/2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
2026-19303, Submission for OMB review; 30-Day Comment Request; the Impact and Costs of Promoting Objectivity in Research 42 CFR Part 50 Subpart F and Responsible Prospective Contractors 45 CFR Part 94 (Office of the Director)
The National Institutes of Health (NIH) is asking for your thoughts on how they collect info to keep research honest and fair. This affects researchers and contractors who work with NIH, aiming to make sure everything stays clear and trustworthy. You’ve got until October 22, 2026, to share your comments—no cost changes, just a check-in to keep things running smoothly!
2026-19156, Proposed Collection; 60-Day Comment Request; Post-Award Reporting Requirements Including Research Performance Progress Report (OD)
The National Institutes of Health (NIH) wants your thoughts on updating how researchers report their progress after getting awards. This affects anyone who receives NIH funding and aims to make reporting clearer and less of a hassle. Comments are due by November 17, 2026, so don’t miss your chance to weigh in!
2026-19155, Proposed Collection; 60-Day Comment Request; PHS Applications and Pre-Award Reporting Requirements (OD)
The NIH is updating how researchers submit their Public Health Service applications and reports before awards, starting May 25, 2026. This change aims to make data management clearer and easier, affecting anyone applying for NIH funding. They want your feedback by November 17, 2026, to help improve the process without adding extra hassle or costs.
2026-18937, Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form (Office of the Director/Office of Intramural Research)
The NIH is rolling out a new online form to make reporting research cheating easier and fairer. Anyone involved with NIH research can use this form to report problems like lying or copying, even anonymously. They want your feedback by November 16, 2026, to make sure the form works well without causing extra hassle.
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute plans to give MedGene Therapeutics an exclusive license to develop and sell special engineered cell treatments for cancers caused by HPV 16 E6. This means MedGene will have the sole right to use these inventions, potentially speeding up new cancer therapies. If you want to comment or apply for a license, you must do so by September 30, 2026.
Previous / Next Documents
Previous: 2026-12584, Civil Service Retirement System; Present Value Factors
The Office of Personnel Management is updating the math used to figure certain Civil Service Retirement benefits starting October 1, 2026. This affects retirees who choose survivor benefits after marriage, owe redeposits, or fix retirement coverage errors. These changes make sure benefits stay fair and match new economic and life expectancy info.
Next: 2026-12586, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension: Rule 19b-7 and Form 19b-7
The SEC is asking for comments to keep using Rule 19b-7 and Form 19b-7, which help certain stock and futures trading groups update their rules smoothly. This affects self-regulatory organizations that oversee trading in security futures products. No big changes or costs are expected, but the SEC wants to make sure everything stays clear and up-to-date.